MedPath

AFT Pharmaceuticals Ltd

AFT Pharmaceuticals Ltd logo
Ownership
-
Employees
110
Market Cap
-
Website
Introduction

AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Aqueous cream, Calci-tab, Maxigesic, Cromo-fresh, Crystaderm, Crytawash, Ellgy plus, Emulsifying ointment, and others. The group has four operating segments based on geographical location being, Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia which includes the sales and distribution activity relating to the Australian market.

Clinical Trials

16

Active:1
Completed:10

Trial Phases

3 Phases

Phase 1:13
Phase 2:2
Phase 4:1

Drug Approvals

1

FDA:1

Drug Approvals

Combogesic

Approval Date
Mar 9, 2023
FDA

Clinical Trials

Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials

Phase 1
13 (81.3%)
Phase 2
2 (12.5%)
Phase 4
1 (6.3%)
No trials found

News

Cell Therapy Advances Show Promise for Hepatocellular Carcinoma Treatment

Cellular therapies including CAR-T cells, NK cells, and tumor-infiltrating lymphocytes demonstrate significant potential for treating hepatocellular carcinoma, with encouraging results in preclinical and clinical trials.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.